Cancer Therapy: CD44v6‐Peptide Functionalized Nanoparticles Selectively Bind to Metastatic Cancer Cells (Adv. Sci. 1/2017)

por Li, Linxian, Schmitt, Mark, Matzke‐Ogi, Alexandra, Wadhwani, Parvesh, Orian‐Rousseau, Veronique, Levkin, Pavel A.
Publicado 2017

CD44v6‐Peptide Functionalized Nanoparticles Selectively Bind to Metastatic Cancer Cells

por Li, Linxian, Schmitt, Mark, Matzke‐Ogi, Alexandra, Wadhwani, Parvesh, Orian‐Rousseau, Veronique, Levkin, Pavel A.
Publicado 2016

Direct binding of hepatocyte growth factor and vascular endothelial growth factor to CD44v6

por Volz, Yvonne, Koschut, David, Matzke-Ogi, Alexandra, Dietz, Marina S., Karathanasis, Christos, Richert, Ludovic, Wagner, Moritz G., Mély, Yves, Heilemann, Mike, Niemann, Hartmut H., Orian-Rousseau, Véronique
Publicado 2015

Functional Genomic mRNA Profiling of Colorectal Adenomas: Identification and in vivo Validation of CD44 and Splice Variant CD44v6 as Molecular Imaging Targets

por Hartmans, Elmire, Orian-Rousseau, Veronique, Matzke-Ogi, Alexandra, Karrenbeld, Arend, de Groot, Derk Jan A., de Jong, Steven, van Dam, Gooitzen M., Fehrmann, Rudolf S.N., Nagengast, Wouter B.
Publicado 2017